Resolvine

N/A

Report date: 2023/02/11 20:39:06
NME

Base Information

Drug NameResolvine
Drug Alias NameResolvine ER
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVitreomacular AdhesionEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKato Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKato Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsVitreomacular AdhesionEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A